Related Experiment Video
Updated: Jan 20, 2026

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
Published on: July 19, 2019
Depression and Suicidality in Multiple Sclerosis: Red Flags, Management Strategies, and Ethical Considerations
Rosalind Kalb1,2, Anthony Feinstein3, Amanda Rohrig4,5
1, West Bath, ME, USA. rkalb@cando-ms.org.
Abstract:
Multiple sclerosis (MS) causes physical, emotional, and cognitive changes that impact function and quality of life (QoL). Risk factors for suicidality in MS patients include a high incidence of depression, increased isolation, and reduced function/independence. PURPOSE OF REVIEW: To describe the epidemiology of depression and suicidality in this population, highlight warning signs for suicidal behavior, provide recommendations and resources for clinicians, and discuss ethical decisions related to patient safety vs. right to privacy. RECENT FINDINGS: Fifty percent of MS patients will experience a major depression related to brain MRI factors and disease-related psychosocial challenges. Nevertheless, depression is under-recognized/treated. The standardized mortality ratio (SMR) indicates a suicide risk in the MS population that is twice that in the general population. Given the prevalence of depression and the increased risk of suicide in the MS population, any clinician providing care for these patients must be prepared to recognize and respond to potential warning signs.
Related Concept Videos
09:41Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
11:35The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool
08:18A Protocol for the Use of Remotely-Supervised Transcranial Direct Current Stimulation (tDCS) in Multiple Sclerosis (MS)
08:11Measuring Progressive Neurological Disability in a Mouse Model of Multiple Sclerosis
Ethics in Research
Fluid-Attenuated Inversion Recovery Magnetic Resonance Imaging to Visualize Multiple Sclerosis Lesions

